Impact of Hidradenitis Suppurativa on Quality of Life Functions

Brief Summary
The goal of this study is to get a better understanding of the impact of Hidradenitis Suppurativa (HS) on the quality of life of patients with this condition. Patients with HS will be asked questions about demographics including gender, age, and ethnicity. They will also be asked to complete questionnaires to determine how their skin condition affects their life. Study participation will last for 1 day, with potential for follow-up in the future. We hope this information will help us improve our treatment for this skin condition.
Brief Title
Impact of Hidradenitis Suppurativa on Quality of Life Functions
Detailed Description
The goal of this study is to get a better understanding of the impact of the skin condition, Hidradenitis Suppurativa, on quality of life function of patients. Patients with HS will be asked questions about demographics including gender, age, and ethnicity. They will also be asked to complete questionnaires to determine how their skin condition affects their life. The questionnaires include Beck Depression Inventory form, which gives us information how you feel about your skin condition and how it changes your mood; Dermatology Life Quality Index (DLQI), which gives us information about how your skin condition affects your quality of life; Skindex, which gives us more specific information about how your skin condition affects your quality of life; SF-36 health survey, which gives us information about your general health status; the Quality of Life Enjoyment and Satisfaction Questionnaire- short form (Q-LES-Q-SF), which gives us information on your enjoyment and satisfaction of your life; and the Employment/Productivity Health Economic Questionnaire, which will give us more information on your work and school status as well as household income. Study participation will last for 1 day, with potential for follow-up in the future. Through potential follow up visits we hope to determine the longitudinal effect of treatment modalities on QoL through future survey performance of the patient cohort. We hope this information will help us improve our treatment for this skin condition.
Completion Date
Completion Date Type
Actual
Conditions
Hidradenitis Suppurativa
Quality of Life
Eligibility Criteria
Inclusion Criteria:

* Clinical diagnosis of hidradenitis suppurativa
* Subject age \>/= 18 years
* Able to be evaluated by a Montefiore physician

Exclusion Criteria:

* No clinical diagnosis of hidradenitis suppurativa
* Subject age \< 18 years
* Subject unable to understand or answer provided questionnaires
* Unable to evaluated by a Montefiore physician
Inclusion Criteria
Inclusion Criteria:

* Clinical diagnosis of hidradenitis suppurativa
* Subject age \>/= 18 years
* Able to be evaluated by a Montefiore physician

Gender
All
Gender Based
false
Keywords
Hidradenitis Suppurativa
Quality of Life
Last Update Submit Date
Maximum Age
99 Years
Minimum Age
18 Years
NCT Id
NCT03288337
Org Class
Other
Org Full Name
Montefiore Medical Center
Org Study Id
2014-3873
Overall Status
Completed
Primary Completion Date
Primary Completion Date Type
Actual
Official Title
Impact of Hidradenitis Suppurativa on Quality of Life Functions: A Cross-Sectional Analysis of 400 Patients
Primary Outcomes
Outcome Description
Quality of life as measured using standardized Dermatology Quality of Life Index
Outcome Measure
Dermatology-related quality of life
Outcome Time Frame
Baseline
Outcome Description
Presence and severity of depression as measured using standardized Beck Depression Inventory
Outcome Measure
Presence and severity of depression
Outcome Time Frame
Baseline
Outcome Description
Quality of life as measured using standardized SkinDex questionnaires
Outcome Measure
Dermatology-related quality of life
Outcome Time Frame
Baseline
Outcome Description
Subject-reported subject health as measured using standardized SF-36 questionnaires
Outcome Measure
Subject-reported subject health
Outcome Time Frame
Baseline
Outcome Description
Degree of enjoyment and satisfaction experienced by subjects in various areas of daily functioning as measured by the standardized Quality of Life Enjoyment and Satisfaction Questionnaire-short form.
Outcome Measure
Degree of enjoyment and satisfaction experienced by subjects in daily functioning.
Outcome Time Frame
Baseline
Outcome Description
Self-reported employment and economic productivity as measured by a standardized health economic questionnaire
Outcome Measure
Employment and economic productivity
Outcome Time Frame
Baseline
Secondary Outcomes
Outcome Description
Change in quality of life as measured using standardized Dermatology Quality of Life Index after treatment initiation
Outcome Time Frame
At 6 months
Outcome Measure
Change in quality of life
Outcome Description
Change in presence and severity of depression as measured using standardized Beck Depression Inventory after treatment initiation
Outcome Time Frame
At 6 months
Outcome Measure
Change in presence and severity of depression as measured using standardized Beck Depression Inventory
Outcome Description
Change in quality of life as measured using standardized SkinDex questionnaires after treatment initiation
Outcome Time Frame
At 6 months
Outcome Measure
Change in quality of life
Outcome Description
Change in subject-reported subject health as measured using standardized SF-36 questionnaires after treatment initiation
Outcome Time Frame
At 6 months
Outcome Measure
Change in subject-reported subject health
Outcome Description
Change in degree of enjoyment and satisfaction experienced by subjects in various areas of daily functioning as measured by the standardized Quality of Life Enjoyment and Satisfaction Questionnaire-short form after treatment initiation
Outcome Time Frame
At 6 months
Outcome Measure
Change in degree of enjoyment and satisfaction experienced by subjects in various areas of daily functioning
Outcome Description
Change in self-reported employment and economic productivity as measured by a standardized health economic questionnaire after treatment initiation
Outcome Time Frame
At 6 months
Outcome Measure
Change in self-reported employment and economic productivity
Start Date
Start Date Type
Actual
Status Verified Date
First Submit Date
First Submit QC Date
Study Population
Healthy adults (ages 18-99) who have a diagnosis of HS (as deemed by a physician at the Hidradenitis Suppurativa Treatment Center at Montefiore Medical Center)
Std Ages
Adult
Older Adult
Maximum Age Number (converted to Years and rounded down)
99
Minimum Age Number (converted to Years and rounded down)
18
Investigators
Investigator Type
Principal Investigator
Investigator Name
Steven Cohen
Investigator Email
srcohen@montefiore.org
Investigator Phone
917-817-9696